Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.09 AUD | -1.55% |
|
+0.58% | -2.11% |
Capitalization | 8.28B 5.43B 4.65B 4.33B 4.01B 7.44B 466B 51.81B 19.79B 218B 20.38B 19.96B 796B | P/E ratio 2025 * |
44.8x | P/E ratio 2026 * | 29.2x |
---|---|---|---|---|---|
Enterprise value | 8.42B 5.53B 4.73B 4.41B 4.08B 7.57B 474B 52.71B 20.13B 222B 20.74B 20.31B 810B | EV / Sales 2025 * |
6.61x | EV / Sales 2026 * | 5.11x |
Free-Float |
58.65% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Telix Pharmaceuticals Limited
More recommendations
More press releases
More news
1 day | -1.55% | ||
1 week | +0.58% | ||
Current month | -1.35% | ||
1 month | -7.27% | ||
3 months | -9.37% | ||
6 months | +0.42% | ||
Current year | -2.11% |
1 week | 23.57 | ![]() | 25.87 |
1 month | 22.76 | ![]() | 26.25 |
Current year | 21.4 | ![]() | 31.97 |
1 year | 17.03 | ![]() | 31.97 |
3 years | 4.37 | ![]() | 31.97 |
5 years | 1.24 | ![]() | 31.97 |
10 years | 0.46 | ![]() | 31.97 |
Manager | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 2017-01-02 | |
Darren Smith
DFI | Director of Finance/CFO | 59 | 2022-07-30 |
Chief Tech/Sci/R&D Officer | - | - |
Director | Title | Age | Since |
---|---|---|---|
Director/Board Member | 50 | 2017-01-02 | |
Mark Nelson
BRD | Director/Board Member | 65 | 2017-09-16 |
Jann Skinner
BRD | Director/Board Member | 67 | 2018-06-18 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
0% | 9 M€ | +15.58% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-1.55% | +0.58% | +37.26% | +342.02% | 5.43B | ||
-0.95% | +1.11% | +10.39% | -1.05% | 50.45B | ||
-0.90% | +3.22% | +73.51% | +34.25% | 30.01B | ||
+1.42% | +5.74% | +4.18% | +11.14% | 28.73B | ||
+2.17% | +0.53% | -22.30% | -24.53% | 28.64B | ||
-0.20% | -0.85% | +26.70% | -22.30% | 12.7B | ||
+1.02% | +1.31% | -53.73% | -30.23% | 12.08B | ||
+0.44% | +1.33% | +28.51% | +88.54% | 10.69B | ||
+1.23% | -0.19% | +17.83% | -5.21% | 10.51B | ||
+2.04% | -2.25% | +70.29% | - | 10.32B | ||
Average | +0.35% | -0.65% | +19.26% | +43.63% | 19.96B | |
Weighted average by Cap. | +0.27% | -0.57% | +16.64% | +14.24% |
2025 * | 2026 * | |
---|---|---|
Net sales | 1.27B 836M 715M 667M 616M 1.14B 71.7B 7.97B 3.04B 33.5B 3.14B 3.07B 122B | 1.62B 1.06B 908M 846M 782M 1.45B 90.99B 10.12B 3.86B 42.51B 3.98B 3.9B 155B |
Net income | 215M 141M 121M 112M 104M 193M 12.08B 1.34B 513M 5.64B 528M 517M 20.63B | 333M 219M 187M 174M 161M 299M 18.75B 2.08B 796M 8.76B 820M 803M 32.01B |
Net Debt | 144M 94.62M 80.96M 75.44M 69.76M 129M 8.11B 902M 344M 3.79B 355M 348M 13.86B | -24.92M -16.35M -13.99M -13.04M -12.06M -22.38M -1.4B -156M -59.53M -655M -61.32M -60.07M -2.39B |
More financial data
* Estimated data
Employees
423
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-07-11 | 24.09 $ | -1.55% | 1,140,941 |
25-07-10 | 24.47 $ | -3.62% | 1,234,472 |
25-07-09 | 25.39 $ | +5.62% | 1,888,127 |
25-07-08 | 24.04 $ | -0.04% | 770,153 |
25-07-07 | 24.05 $ | -0.58% | 441,596 |
Delayed Quote Australian S.E., July 11, 2025 at 02:10 am EDT
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
10
Last Close Price
24.47AUD
Average target price
32.05AUD
Spread / Average Target
+30.97%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions